
Processing of chromogranins/secretogranin in patients with diabetic retinopathy
Keywords: A1AT; alpha1-antitrypsin; CgA; chromogranin A; CgB; chromogranin B; DR; diabetic retinopathy; DV; diabetic vitreous; HbA1C; glycated haemoglobin; HRB; hematoretinal barrier; nanoLC-MS/MS; nano-liquid chromatography-mass spectrometry/mass spectrometry; N